1100 Melville Street
Suite 888
Vancouver, BC V6E 4A6
Canada
604-669-0555
https://ondinebio.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Carolyn M. Cross C.F.A., CFA, M.B.A., MBA | Founder, CEO & Executive Director | 493.37k | N/A | N/A |
Dr. Nicolas G. Loebel Ph.D. | President, CTO & Executive Director | 576.4k | N/A | N/A |
Dr. Simon Sinclair Ph.D. | Chief Medical Officer & Director | 71.89k | N/A | 1972 |
Mr. William Kanz | Senior VP of Engineering & Operations | N/A | N/A | N/A |
Ms. Angelika Vance | Vice President of Corporate Communications | N/A | N/A | N/A |
Mr. Matt Ross | Vice President of Sales & Marketing | N/A | N/A | N/A |
Ms. Elaine Lei CPA | Corporate Controller | N/A | N/A | N/A |
Mr. Nikita Parkev | VP of Finance & Company Secretary | N/A | N/A | N/A |
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its product platform is Photodisinfection, a light-based antimicrobial technology that provides destruction of pathogens without causing antibiotic resistance. The company's lead product is Steriwave, a nasal photodisinfection solutions that destroys bacteria, viruses, and fungi colonizing the nose which leads to healthcare-associated infections. Its product pipeline also includes the development of topical antiviral therapy for the upper respiratory tract to reduce SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
Ondine Biomedical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.